13F Pro

SEC Form 4 reporting owner

Paolini John F.

Paolini John F. has filed 24 Form 4 transactions reported between March 2, 2026 and September 1, 2026, as CHIEF MEDICAL OFFICER of Kiniksa Pharmaceuticals International, plc.

Name as filed: Paolini John F.

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$4.9M
5 lines
Companies
1
with Form 4 filings
Latest transaction
Sep 1, 2026
transaction date

Roles and reported holdings

  • KNSAKiniksa Pharmaceuticals International, plc
    Mar 2, 2026 – Sep 1, 2026

    CHIEF MEDICAL OFFICER

    Held directly69,922 sh as of Sep 1, 2026 · Form 4

    24 months: $4.9M sold

Transaction history

All 24 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 1, 2026KNSACHIEF MEDICAL OFFICERGrant or awardCode A · direct26,750—Form 4
Sep 1, 2026KNSACHIEF MEDICAL OFFICERGrant or awardCode A · direct6,700—Form 4
Sep 1, 2026KNSACHIEF MEDICAL OFFICERShares withheld for tax or exercise priceCode F · direct4,029$319K@ $79.28Form 4
Sep 1, 2026KNSACHIEF MEDICAL OFFICEROption exerciseCode M · direct2,457—Form 4
Sep 1, 2026KNSACHIEF MEDICAL OFFICEROption exerciseCode M · direct1,750—Form 4
Sep 1, 2026KNSACHIEF MEDICAL OFFICEROption exerciseCode M · direct1,624—Form 4
Sep 1, 2026KNSACHIEF MEDICAL OFFICEROption exerciseCode M · direct2,497—Form 4
May 1, 2026KNSACHIEF MEDICAL OFFICEROpen-market saleCode S · direct21,097$1.1M@ $54.04Form 4
May 1, 2026KNSACHIEF MEDICAL OFFICEROpen-market saleCode S · direct37,327$2.0M@ $53.52Form 4
May 1, 2026KNSACHIEF MEDICAL OFFICEROption exerciseCode M · direct58,424$605K@ $10.36Form 4
Apr 7, 2026KNSACHIEF MEDICAL OFFICERShares withheld for tax or exercise priceCode F · direct1,208$59K@ $48.94Form 4
Apr 7, 2026KNSACHIEF MEDICAL OFFICEROption exerciseCode M · direct2,497—Form 4
Apr 1, 2026KNSACHIEF MEDICAL OFFICEROption exerciseCode M · direct2,457—Form 4
Apr 1, 2026KNSACHIEF MEDICAL OFFICEROption exerciseCode M · direct1,750—Form 4
Apr 1, 2026KNSACHIEF MEDICAL OFFICEROption exerciseCode M · direct1,624—Form 4
Apr 1, 2026KNSACHIEF MEDICAL OFFICERGrant or awardCode A · direct13,400—Form 4
Apr 1, 2026KNSACHIEF MEDICAL OFFICERGrant or awardCode A · direct6,700—Form 4
Apr 1, 2026KNSACHIEF MEDICAL OFFICERGrant or awardCode A · direct26,750—Form 4
Apr 1, 2026KNSACHIEF MEDICAL OFFICERShares withheld for tax or exercise priceCode F · direct2,821$136K@ $48.13Form 4
Apr 1, 2026KNSACHIEF MEDICAL OFFICEROption exerciseCode M · direct5,831—Form 4
Mar 2, 2026KNSACHIEF MEDICAL OFFICEROpen-market saleCode S · direct5,714$262K@ $45.92Form 4
Mar 2, 2026KNSACHIEF MEDICAL OFFICEROpen-market saleCode S · direct22,223$997K@ $44.88Form 4
Mar 2, 2026KNSACHIEF MEDICAL OFFICEROpen-market saleCode S · direct12,063$533K@ $44.20Form 4
Mar 2, 2026KNSACHIEF MEDICAL OFFICEROption exerciseCode M · direct40,000$414K@ $10.36Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.